Method of blocking immune complex binding to immunoglobulin FC receptors
US4752601A · kind A · utility
97Cited by
6References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 1, 1986 |
| Grant date | Jun 21, 1988 |
| Priority date | — |
| Expiry date | Apr 1, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of modulating immune complex mediated immune responses in mammals is described, comprising administering a peptide comprising the amino acid sequence EQU -Thr-Ile-Ser-Lys-Ala-Lys-Gly-Gln-Pro-Arg- Specific uses in reducing immune complex mediated inflammation or tissue destruction and in modulating the proliferation or function of mononuclear cells are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.